2 completed, 1 not yet recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
Follow SOFIE: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary 177Lu-FAP-2286 - Cancer of Unknown Primary | Phase 2 | Not yet recruiting | Peter MacCallum Cancer Centre, Australia | 20 | 2026-06-01 | 2026-02-25 |
| Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [18F]FAPI-74 PET/CT - Gastrointestinal Cancers, Cholangiocarcinoma | Phase 2 | Completed | SOFIE | 112 | 2023-04-28 | 2026-10-01 |
| Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma [68Ga]FAPI-46 - PDAC - Pancreatic Ductal Adenocarcinoma, FAP | Phase 2 | Completed | SOFIE | 63 | 2022-05-02 | 2026-05-29 |
Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Stomach Neoplasms (1)
FAPI-46 (1)
United States (2) · Australia (1)
Linda Mileshkin (1)